Also listed on Bluebird Bio, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Jun 8, 2032 · High confidence
20-year base term ends Jun 8, 2032
Held by Genetix Biotherapeutics Inc.
Filed Jun 8, 2012 as application 13/492,553 · Granted Oct 14, 2014
Base term, 20 years from filing
Today
2012
2032
Clock starts
Jun 8, 2012
Jun 8, 2012
Term ends
Jun 8, 2032
Jun 8, 2032
Granted
Oct 14, 2014
Oct 14, 2014
base term
fee events
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 8, 2012, when this application, 13/492,553, was filed | Jun 8, 2032 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jun 8, 2032 | High confidence |
This family
| US 8,858,928 | this patent Jun 2032 | Jun 2032 |
| US 9,061,031 | In force no later than Jun 2032 | no later than Jun 2032 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 21, 2012 Reel 29003, frame 671 | Denaro, Maria Joann; Finer, Mitchell Howard; Veres, Gabor | Bluebird Bio, Inc. | Assignment of Assignor's Interest |
| Jun 27, 2014 Reel 33196, frame 515 | Down, Julian | Bluebird Bio, Inc. | Assignment of Assignor's Interest |
| Mar 15, 2024 Reel 66801, frame 818 | Bluebird Bio, Inc. | Hercules Capital, Inc., as Agent | Security Interest |
| Sep 25, 2025 Reel 72955, frame 154 | Bluebird Bio, Inc. | Genetix Biotherapeutics Inc. | Change of Name |
| Nov 2, 2026 Reel 76600, frame 706 | Hercules Capital, Inc., as Agent | Genetix Biotherapeutics Inc. (F/K/A Bluebird Bio, Inc.) | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Jun 2032
Term ends Jun 8, 2032. No further fees fall due before then
Citations
30
later US patents cite this one
That is top 25% of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.